Ractigen Therapeutics

12/01/2023

We are delighted to have Harri Järveläinen join Ractigen Therapeutics as our Chief Operating Officer!
https://finance.yahoo.com/news/ractigen-therapeutics-announces-appointment-harri-120000122.html

08/03/2018

http://www.jurology.com/article/S0022-5347(17)77821-4/fulltext

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

08/03/2018

https://www.sciencedirect.com/science/article/pii/S135727251830030X?via%3Dihub

Recent studies have reported that chemically synthesized double-stranded RNAs (dsRNAs), also known as small activating RNA (saRNAs), can specifically …

08/03/2018

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193590

Short-activating RNA (saRNA), which targets gene promoters, has been shown to increase the target gene expression. In this study, we describe the use of an saRNA (Flt a-1) to target the flt-1 promoter, leading to upregulation of the soluble isoform of Flt-1 and inhibition of angiogenesis. We demonst...

08/03/2018

Short-activating RNA (saRNA), which targets gene promoters, has been shown to increase the target gene expression. In this study, we describe the use of an saRNA (Flt a-1) to target the flt-1 promoter, leading to upregulation of the soluble isoform of Flt-1 and inhibition of angiogenesis. We demonst...